Lv1
40 积分 2026-03-06 加入
Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells
1小时前
已完结
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
1小时前
已完结
Harnessing B19-directed CAR T cells for AAV vector administration in seropositive patients: The importance of the niche
2个月前
已关闭
In vivo chimeric antigen receptor (CAR)-T cell therapy
2个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
2个月前
已完结
mRNA lipid nanoparticles in CAR-T therapy: a novel strategy to improve efficacy
2个月前
已完结
Acute lymphoblastic leukaemia
2个月前
已完结
A T-ALL order: a new risk classifier for T-ALL
2个月前
已完结
Characterization of engineered CAR-Treg cells to induce immune tolerance in liver transplanted patients
3个月前
已关闭
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
3个月前
已完结
皖公网安备34019202002308
